We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Outpatient Cervical Ripening Safely Shortens Inpatient Labor

By HospiMedica International staff writers
Posted on 26 Jan 2022
Women who undergo at-home balloon catheter cervical ripening spend less time in hospital than those who undergo a prostaglandin induction procedure, according to a new study.

Researchers at Thomas Jefferson University (TJU; Philadelphia, PA, USA), The Women’s Hospital (Newburgh, IN, USA), and other institutions examined six studies involving 571 low-risk patients with singleton gestations (of at least 37 weeks) in order to evaluate whether outpatient cervical ripening with a balloon catheter results in a shorter amount of time in the labor and delivery unit, when compared with medical induction use in the inpatient setting.

The results revealed that the outpatient group had a mean 16.3 hours in the labor and delivery unit, as compared with 23.8 hours for the inpatient group, a difference of 7.24 hours. More...
The researchers also observed a significant 24% decreased risk of cesarean delivery, and no stillbirths were reported. Demographically, body mass index (BMI) was lower in the outpatient group, with no differences in maternal age, gestational age at induction, or parity. The study was published on January 6, 2022, in Obstetrics & Gynecology.

“We knew induction was good in the hospital for many indications. We now know that induction can be started at home, and it's safe,” said corresponding author Vincenzo Berghella, MD, director of the maternal-fetal medicine at TJU. “The lower rate of cesarean delivery in the outpatient group likely reflected less use of fetal heart-rate monitoring, which can produce false-positive predictions of fetal compromise.”

Balloon catheters have been used for labor induction as far back as the 1890s. It has been postulated that the mechanical stretching by the catheter balloon causes an increased release of endogenous prostaglandins, which in turn cause cervical ripening, and without significant uterine contractions or systemic side effects in mothers. Expulsion of the balloon catheter usually occurs when a cervical dilation of about four cm is evident.

Related Links:
Thomas Jefferson University
The Women’s Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.